- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
National insurer targets outpatient imaging centers
The American College of Radiology has seen regional victories related to its campaign to have insurers enact methods to guarantee quality and appropriateness. In January, the UnitedHealth Group, which serves 70 million individuals nationwide, announced it wants outpatient imaging facilities in all 50 states to be accredited by next March.
The American College of Radiology has seen regional victories related to its campaign to have insurers enact methods to guarantee quality and appropriateness. In January, the UnitedHealth Group, which serves 70 million individuals nationwide, announced it wants outpatient imaging facilities in all 50 states to be accredited by next March.
UnitedHealth's accreditation program targets freestanding outpatient facilities and physician offices that perform CT and CT angiography, MRI and MR angiography, nuclear medicine, nuclear cardiology, PET, and echocardiography services.
"While it's a move in the right direction, payers should also ensure that patients receive the appropriate exam and that the exam is not the result of inappropriate self-referral," said Dr. Alan Kaye, a member of the ACR steering committee.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
